PT - JOURNAL ARTICLE AU - Cooter, Mary AU - Bunning, Thomas AU - Eleswarpu, Sarada S. AU - Heflin, Mitchell T. AU - McDonald, Shelley AU - Lagoo-Deenadalayan, Sandhya AU - Whitson, Heather AU - Deiner, Stacie G AU - Berger, Miles TI - A Processed EEG based Brain Anesthetic Resistance Index Predicts Postoperative Delirium in Older Adults: A Dual Center Study AID - 10.1101/2021.01.07.21249360 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.07.21249360 4099 - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249360.short 4100 - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249360.full AB - Background Some older adults show exaggerated responses to drugs that act on the brain, such as increased delirium risk in response to anticholinergic drugs. The brain’s response to anesthetic drugs is often measured clinically by processed electroencephalogram (EEG) indices. Thus, we developed a processed EEG based-measure of the brain’s neurophysiologic resistance to anesthetic dose-related changes, and hypothesized that it would predict postoperative delirium.Methods We defined the Duke Anesthesia Resistance Scale (DARS) as the average BIS index divided by the quantity 2.5 minus the average age-adjusted end-tidal MAC (aaMAC) inhaled anesthetic fraction. The relationship between DARS and postoperative delirium was analyzed in derivation (Duke; N=69), validation (Mt Sinai; N=70), and combined estimation cohorts (N=139) of older surgical patients (age ≥65). In the derivation cohort, we identified a threshold relationship between DARS and for delirium and identified an optimal cut point for prediction.Results In the derivation cohort, the optimal DARS threshold for predicting delirium was 27.0. The delirium rate was 11/49 (22.5%) vs 11/20 (55.0%) and 7/57 (12.3%) vs 6/13 (46.2%) for those with DARS ≥ 27 vs those with DARS < 27 in the derivation and validation cohorts respectively. In the combined estimation cohort, multivariable analysis found a significant association of DARS <27.0 with postoperative delirium (OR=4.7; 95% CI: 1.87, 12.0; p=0.001). In the derivation cohort, the DARS had an AUC of 0.63 with sensitivity of 50%, specificity of 81%, positive predictive value of 0.55, and negative predictive value of 0.78. The DARS remained a significant predictor of delirium after accounting for opioid, midazolam, propofol, non-depolarizing neuromuscular blocker, phenylephrine and ketamine dosage, and for nitrous oxide and epidural usage.Conclusions These results suggest than an intraoperative processed EEG-based measure of lower brain anesthetic resistance (i.e. DARS <27) could be used in older surgical patients as an independent predictor of postoperative delirium risk.Competing Interest StatementNo authors or any close family members have any financial stake, stock, or other interest in Medtronic or Covidien. Dr. Deiner has served as a consultant for Medtronic Boulder CO and Merck as has served as an expert legal witness. MB acknowledges receiving material support (monitors) from Masimo for another study unrelated to this manuscript, and private consulting income from two legal cases regarding postoperative cognition.Funding StatementDr. Berger acknowledges support from a mentored research grant from the International Anesthesia Research Society; NIH grants R03-AG050918 and K76-AG057022, and additional support from NIH grants T32-GM08600 and P30AG028716; a small project grant from the American Geriatrics Society; a Jahnigen Scholar Award from the Foundation for Anesthesia Education and Research and the American Geriatrics Society; and the Duke Private Diagnostic Clinic ENABLE program and Duke Anesthesiology Department. Dr. Whitson's contributions were supported by the Duke Claude D. Pepper Older American Independence Centre [P30AG028716]; the Physical Resilience Indicators and Mechanisms in the Elderly (PRIME) Collaborative [UH2AG056925]; and National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002553]. Dr. Deiner acknowledges support from the American Federation of Aging Beeson Program and NIH K23-AG048332.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Duke University Medical Center IRB, Mt. Sinai Medical Center IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.